Optimal Perioperative Management of Antithrombotic Agents in Patients with Chronic Subdural Hematoma

Chronic subdural hematoma (CSDH) is a common form of intracranial hemorrhage, and recurrences and complications are well-documented in affected patients. No consensus has been reached regarding whether antithrombotic therapy is a predictive factor associated with postoperative complications and recurrence in patients with CSDH [1 –14]. This may be a result of different antithrombotic agent management regimens such as alternative courses of continuation or termination and different timing of cessation and resumption of antithrombotic agents.

Source: Clinical Neurology and Neurosurgery - October 6, 2016 Category: Neurosurgery Authors: Toshiyuki Amano, Kenta Takahara, Naoki Maehara, Takafumi Shimogawa, Nobutaka Mukae, Tetsuro Sayama, Shoji Arihiro, Shuji Arakawa, Takato Morioka, Sei Haga Source Type: research